The role of the X region of the genome of the human T-cell leukemia virus type I (HTLV-I) in the hmmortalization of lymphocytes has been difficult to distinguish from its role in viral replication as this region encodes at least two genes, tax and rex, required for replication and the expression of viral proteins. To determine whether the X region does encode immortalizing functions, a fragment of the HTLV-I provirus capable of expressing known X-region proteins was inserted into the genome of a transformation-defective, replication-competent Herpesvirus saimiri. Infection of fresh mitogen-activated human cord blood and thymocytes yielded immortal T-cell lines that had the same phenotype (CD4+, CD5+, HLA class HII, interleukin 2 receptor a-chain +) as lymphocytes transformed by cocultivation with HTLV-I. These experiments demonstrate that the X region encodes the functions of HTLV-I that immortalize a distinct subpopulation of human T cells. The experiments also demonstrate the utility of the H.
The human T-cell leukemia virus type I (HTLV-I) (1), a retrovirus, is the etiological agent of adult T-cell leukemialymphoma (ATLL), an aggressive neoplasm of CD4+ T cells. Tumor cell lines derived from ATLL patients retain many ofthe characteristics of the tumor cells themselves, including detectable levels of surface CD4 and interleukin 2 (IL-2) receptor (2, 3) . Typically, ATLL-derived cell lines also produce HTLV-I virus particles (4) . Fresh human T cells may be altered to permanent growth by cocultivation with the virus-producing ATLL cell lines, and the T cells so derived closely resemble tumor cell lines established from patients (5) (6) (7) . These observations suggest that HTLV-I possesses an immortalizing genetic function. Molecular and biochemical studies reveal that in addition to the genes common to all retroviruses encoding virion structural proteins and replicative enzymes, the genome of HTLV-I contains an additional segment of 1600 nucleotides located near the 3' end called the X region (8) . It has been proposed that the X region encodes the immortalizing functions of the virus. However, it has been difficult to distinguish immortalization from replication functions as the X region encodes at least two genes, the trans-activator gene, tax (9, 10) , and the regulator of expression of virion proteins, rex (11, 12) , that are required for virus replication.
To determine whether the X region encodes the gene products that induce immortalization as well as replication functions, a segment of a HTLV-I provirus capable of expression of known X-region functions was inserted into the genome of a transformation-defective, replication-competent 
MATERIALS AND METHODS
Preparation of Recombinant H. saimiri. H. saimiri and viral DNA were prepared as described (13, 14) . To obtain recombinant viruses, the plasmids pSIneo and pRU neo were cut with Kpn I and EcoRI, respectively, and added to genomic DNA of H. saimiri strain 11S4. Plasmid (2-4 ,ug) and viral DNAs (0.2-0.4 ,g) were cotransfected into OMK cells using the calcium phosphate method (15) . Two viral stocks (I and II) were obtained from cotransfection with prUneoHI (I) and pSIneoHI (II). Selection and purification of recombinants will be described elsewhere (37) . Briefly, virus from both stocks was passaged three times on G418-treated OMK cells. Single viral plaques were isolated, expanded, and assayed for the presence of heterologous sequences by dot spot hybridization, using 32P-labeled pHISL-ESX DNA. Viral stocks resulting from plaques II-1, II-40, III-21, III-22, and III-38 were analyzed in closer detail.
Characterization of Recombinant Viruses. For Southern blot analysis, viral and cellular DNA was extracted as described (16, 37 (21) . Forty-eight hours later these cells were lysed, and -10 cell equivalents was loaded into a 12% reducing acrylamide gel. In addition, infected cell lines were lysed, 106 live cell equivalents was loaded, and the proteins were electrophoresed and electroblotted onto nitrocellulose. Antiserum from HTLV-I-infected patients was allowed to bind to the filter overnight at room temperature and specific proteins were detected using an alkaline phosphataseconjugated anti-human immunoglobulin and the appropriate substrates (Promega). were labeled overnight with [35S]cysteine, washed, and lysed. The supernatants were then precipitated with preimmune rabbit serum prior to precipitation with rabbit antipeptide antiserum to remove nonspecific proteins. The infected cell lysates were then precipitated with the rabbit antipeptide antiserum specific for p27rcx and p21rcx (described in the text) that had been preabsorbed with uninfected, unlabeled cell lysates to remove nonspecific activity. The resulting immunoprecipitated proteins were analyzed by electrophoresis on a 12% reducing acrylamide gel followed by autoradiography.
Trans-Activation Assay. Cells (5 x 106) were transfected with 2 1Lg of the appropriate plasmid using DEAE-dextran as described (21) . Forty-eight hours after transfection, the cells were counted and lysed, and 4 x 105 live cell equivalents was assayed unless otherwise noted for chloramphenicol acetyltransferase (CAT) activity. Results represent percentage conversion to the acetylated form of chloramphenicol after a 15-min enzymatic assay. RESULTS To examine the immortalizing potential of the X region of HTLV-I, apart from its demonstrated role in virus replication, it was necessary to introduce this region into a suitable target cell population in the absence of the replicative genes and in a form in which all potential X-region functions might be expressed. H. saimiri was selected as the vector as it is capable of infecting New World primate and human T lymphocytes (22, 37) . Although H. saimiri is capable of transforming CD8' T cells (which also possess markers ofthe natural killer lineage) of some New World primates, repeated attempts to transform human lymphocytes, including cord blood lymphocytes, have been unsuccessful (ref. 16 ; R.G. and B.F., unpublished data). Nonetheless, as an additional assurance that the effect of X-region expression would be observed in the absence ofH. saimiri transforming functions, the actual vector used for these experiments was the deleted H. saimiri strain 11S4 (23) . The S4 deletion removes -3.5 kilobases (kb) of genetic information from the left terminal part of the (A + T)-rich region of the genome. The deleted virus S4 is capable of replication but is transformationdefective as judged by the failure of the virus to induce T-cell lymphomas in susceptible New World primates and by the failure to transform lymphocytes from these animals in tissue culture (24) (25) (26) (27) .
The sequences of HTLV-I used for these studies include all of the region between the 3' end of the envelope gene and the 3' long terminal repeat (LTR). A short region that overlaps the 3' end of the pol gene and the 5' end of the envelope gene was also included, as this region contains an exon that is joined by splicing to the X region. The entire 3' LTR is also present. The segment ofthe HTLV-I provirus used was obtained by deletion of HTLV-I gag and pol sequences and an internal deletion of envelope gene sequences. Some envelope sequences 3' to the splice donor and 5' to the end of the envelope gene were retained, as these sequences may affect expression of the first or second coding exons oftax and rex (for nomenclature review, see ref. 28) . It is also possible that the sequences near the 3' end of the envelope gene are required for expression ofinformation in the NCR region of X that contains several open reading frames that have the potential to encode proteins in addition to tax and rex. The fragments ofthe envelope gene that remain are predicted to be joined out of the correct reading frame. No products of envelope-related proteins were detected in experiments reported here (see below) or in other experiments with this plasmid (M.-C.D., K.M., and W.A.H., unpublished data).
The promoter used for expression of the HTLV-I proteins is the LTR of the murine retrovirus SL3-3. The SL3-3 promoter has been shown to direct high levels of RNA and protein synthesis in murine and human T cells (29 (32) , representing the 3' half of the virus was used. The majority of the env was deleted by a Sal I (nucleotide 5694) to Xho I (nucleotide 6518) deletion (SAX). This HTLV-I sequence was fused to the SL3-3 (murine retrovirus) enhancer promoter contained in the Xho I (X) HindI1 (H) fragment (29) . The resulting expression cassette was shown to express p421ax activity using pU3RI-CAT as an indicator. To insert the cassette into the unique Sal I (S) site of pRUneo and pSIneo, the Sac I site was transformed into a Xho I site by use of T4 DNA polymerase and linkers. The plasmid pSIneo (37) contains the neo gene under the transcriptional control of the simian virus 40 early region promoter and the Kpn I-E fragment originating from the right L-DNA border of H. saimiri 11 (19) . The plasmid pR~neo is a deletion variant of pSIneo, lacking two EcoRI (e) fragments. The resulting plasmids were designated as pRUneoH1 and pSIneoH1, respectively. and p27rex. Preparatory to introduction into the H. saimiri vector, the HTLV-I sequences were placed into the plasmids pRUneo and pSIneo such that they were adjacent to H. saimiri sequences (Fig. 1) . The viral DNA ofH. saimiri strain 11S4 was cotransfected with the HTLV-I X plasmids onto OMK cells. The newly developed cloning strategy (R.G. and B.F., unpublished data) differed from earlier strategies to insert heterologous DNA as the heterologous sequences are inserted at the right terminus of the unique H. saimiri DNA (26) . Recombinant virus was selected on OMK cells in the presence of the antibiotic G418, and plaques containing HTLV-I X DNA were identified by hybridization with radioactive DNA prepared from the HTLV-I X region. The recombinants were all found to contain the complete unrearranged HTLV-I X-region sequences by restriction enzyme and Southern blot analysis (not shown). Further restriction analysis of the recombinant H. saimiri genomes revealed no detectable rearrangements outside of the region where the recombinant events occurred (not shown). The H. saimiri recombinants express X-region RNA and p27rex protein as well as p42tax activity and protein upon lytic infection of OMK cells using antiserum raised to the nine carboxylterminal amino acids of the p27rex protein and the ATLL patient antiserum, respectively (not shown).
The effect of infection by the H. saimiri-HTLV-I X recombinants on fresh human thymocytes and cord blood cells was examined. The cells were stimulated with PHA and, in the thymocyte experiment, phorbol ester (PMA) prior to infection and were grown in the presence of IL-2 after infection. In parallel, stimulated thymocytes were also cocultivated with mitomycin C-treated HTLV-I-producing cell lines [HUT 102 (1) and C91PL (7)]. A separate aliquot of the cells was also infected with the H. saimiri 11S4 deletion mutant. Continuous growth was observed in almost all thymus and in all cord blood cultures infected with the H. saimiri-HTLV-I X recombinants as well as in those populations cocultivated with HTLV-I-producing cells. All cultures have been maintained for a minimum of 36, and some 47, weeks after infection. In contrast, after 8 weeks, no viable cells were found in untreated control cultures or in cultures infected with the H. saimiri 11S4 virus. To determine whether the cell populations were dependent on IL-2, the cultures were split and a portion was maintained in the same medium lacking IL-2. None of the cultures remained viable for >10 days in the absence of IL-2. All thymocyte-derived cultures, including those infected with HTLV-I, have a doubling time of -30 hr. The doubling time for all of the cord blood cell cultures transformed by the H. saimiri recombinants is between 4 and 6 days at 30 weeks in culture.
The expression of lymphocyte markers was examined in these cell populations by using indirect immunofluorescence (Fig. 2) . The amount of fluorescence was quantitated by flow cytometry. All cultures were found to express the T-cell surface markers CD4 and CD5 but were negative for CD8. In addition, all lines tested were found to express major histocompatibility complex class II (DR) molecules (not shown). All cultures were also found to express the receptor for IL-2 using an antibody specific for the 55-kDa a-chain (see Fig. 2 , third horizontal panel).
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Cell surface expression of T-cell markers in HTLV-I X-region transformed thymocyte lines. Lymphocyte lines were tested for cell surface expression of the indicated antigens using monoclonal antibodies. The fluorescein-conjugated second antibody alone was the negative control as depicted by the left-most peak in each panel. Fluorescence intensity is plotted on the abscissa versus cell number. Thy-C91 was derived from a cocultivation of normal thymocytes with the HTLV-I-infected line, C91PL. Thy-1 and Thy-38 are two lines derived from infection with H. saimiri HTLV-I X-region recombinants. Similar results were obtained with two other thymocyte lines, Thy-HUT (see Table 1) It is reported the H. saimiri DNA exists as episomal DNA in marmoset lymphoid tumor cell lines (18, 33) . Examination of the thymocyte and cord blood cell lines using Gardellatype gels (17) , which reveal the presence of episomal DNA after in situ lysis of the cells in the well ofthe gel, showed that the HTLV-I X sequences also exist as large episomes (150-200 kb) at high multiplicity (about 100 copies per cell) (Fig. 3) . The size and number of genome copies per cell were estimated for the cord blood lines from comparison with H. saimiri-transformed tumor cell line 1670 (22) .
Restriction enzyme digestion followed by Southern blot analysis revealed intact X-region DNA in the thymocyte and cord blood cell lines infected with the H. saimiri recombinants. Total RNA was extracted from these cultures and analyzed by using a radioactive probe to the HTLV-I Xregion DNA. RNA was also extracted from HTLV-I-infected cell lines. RNA species corresponding to the full-length transcript, the mRNA encoding the envelope glycoprotein, and the mRNAs corresponding to the tax and rex products were detected as reported (30, 32, 34) in the HUT 102 cell line as well as in thymocyte lines derived by cocultivation with HUT 102 and C91PL. RNAs of :3.8 kb and -2.0 kb were detected in cells infected with the H. saimiri-HTLV-I X recombinants (Fig. 4) . These species correspond to the full-length transcript initiated within the SL3-3 LTR and the major spliced product. The ratio of full-length transcript to spliced HTLV-I RNA is =10:1, as determined by densitometry tracing of one of the autoradiograms.
To determine whether any of the X-region functions were expressed in the H. saimiri recombinant transformed lymphocytes, the ability of these cells to express tax and rex proteins was analyzed. Western blot analysis using an ATLL patient antiserum demonstrated in Fig. 4B that the cell lines produce p42t11. No truncated envelope protein product is detected in these cells by patient antiserum that recognizes the env proteins. To determine whether the tax product detected was active, several of the H. saimiri-HTLV-I X-infected lines and cultures cocultivated with HTLV-I were transfected with the indicator plasmid pU3R1-CAT (35) that contains the HTLV-I LTR located 5' to the bacterial gene for CAT. The relative activity of the pU3R1-CAT and pRSV-CAT plasmids was determined in the Jurkat T-cell line that does not contain HTLV-I sequences. The results of the experiment summarized in Table 1 demonstrate that all ofthe H. saimiri-HTLV-I X-infected lines tested express active p42tax. Immunoprecipitation with anti-rex antiserum revealed that the thymocyte cultures infected with the H. saimiri-HTLV-I X recombinants tested express p27reX (Fig. 4) . The cultures cocultivated with HUT 102 and C91PL also express p27rex (Fig. 4, lane 1) . The results presented here demonstrate that the region of the HTLV-I virus present in the H. saimir-HTLV-I X recombinants confers the ability to transform to continuous IL-2-dependent growth primary human lymphocytes derived from cord blood and thymus. The phenotype of the cells closely resembles that of ATLL tumor cells and of cells derived in culture by cocultivation with HTLV-I-producing cell lines. The H. saimiri-HTLV-I X-transformed human cells are CD4', CD8-and express high levels of IL-2 receptor. The infected cultures are capable of prolonged growth in the presence of IL-2. This report demonstrates a role of the X region in immortalization independent of its role in replication. The immortalizing ability of the HTLV-I X region does not require the gag, pol, or intact env proteins of the virus. These experiments also demonstrate that the X region determines the phenotype of the cell as it is unlikely that the HTLV-I and H. saimiri share the same surface receptor. We think it unlikely that H. saimiri-encoded activities contribute directly to immortalization for the following reasons. H. saimiri does not transform human cord blood or thymic lymphocytes (16) . The S4 deletion variant used for these experiments does not even transform New World primate lymphocytes. Moreover, the phenotype of the transformed cells is typical of HTLV-I-transformed cells and differs from the phenotype of New World primate cells transformed by the parental H. saimiri (36) . The phenotype of the cells immortalized by the H. saimiri-HTLV-I X recombinant is precisely that of cells immortalized by HTLV-I. These experiments do not address which of the potential X-region products specify the immortalizing functions. The cell lines do express the known X-region-encoded proteins, including tax and rex. In addition to those proteins, several other open reading frames in the X region exist that may specify additional proteins. The role of each of the potential X-region products in immortalization is now amenable to study using mutants introduced into the H. saimiri vector. The experiments also demonstrate the utility of the H. saimiri vector for studies ofgene expression in human lymphocytes.
